12:00 AM
Jul 16, 2012
 |  BC Week In Review  |  Company News  |  Other News

Actelion autoimmune, cardiovascular news

Actelion said it will cut up to 135 positions, or about 5% of its approximately 2,500 employees, as part of a plan announced in May to reduce spending by refocusing R&D activities on specialty areas. The cuts will affect R&D and administration. Actelion is also conducting a...

Read the full 215 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$35 USD
More Info >